US FDA approves Alvesco inhaler for treatment of asthma

Published: 2008-01-30 07:00:00
Updated: 2008-01-30 07:00:00
Handok Pharm says the US Food and Drug Administration approved Swiss based Nycomed's Alvesco (ciclesonide) Inhalation Aerosol in the United States for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

Handok gained Alvesco...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.